We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

125 hedge funds and large institutions have $34.8M invested in Sanofi Contingent Value Rights in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 27 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 130 → 125 (-5)

15% less capital invested

Capital invested by funds: $40.7M → $34.8M (-$5.98M)

19% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 27

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
125
Holders Change
-5
Holders Change %
-3.85%
% of All Funds
3.61%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
22
Reduced
27
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCM
Gruss Capital Management
New York
+$929K
2
PWAM
Park West Asset Management
California
+$864K
3
SM
Scoggin Management
New York
+$743K
4
Brown Advisory
Brown Advisory
Maryland
+$483K
5
Citigroup
Citigroup
New York
+$372K

Top Sellers

Rank Fund Capital Flow
1
ACM
Abrams Capital Management
Massachusetts
-$3.96M
2
SI
Standard Investments
New York
-$819K
3
PI
Putnam Investments
Massachusetts
-$427K
4
AGCJ
Alden Global Capital (Jersey)
Jersey
-$425K
5
WA
Whitebox Advisors
Minnesota
-$360K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAS
51
CTC Alternative Strategies
Illinois
$23.5K – – –
KAM
52
Knightsbridge Asset Management
California
$23K -$335 -900 -1%
IRF
53
IBM Retirement Fund
New York
$22K – – –
ACA
54
Anchor Capital Advisors
Massachusetts
$19K -$955 -2,570 -4%
Korea Investment Corp
55
Korea Investment Corp
South Korea
$16K – – –
CCA
56
Castle Creek Arbitrage
Colorado
$13K -$125K -335,521 -89%
DBG
57
De Burlo Group
Massachusetts
$13K +$15K +40,300 New
Commonwealth Equity Services
58
Commonwealth Equity Services
Massachusetts
$12K +$490 +1,319 +4%
WHI
59
William Harris Investors
Illinois
$10K – – –
CHAM
60
Clear Harbor Asset Management
Connecticut
$10K +$12.5K +33,635 New
OC
61
Oppenheimer & Co
New York
$9K -$93 -250 -0.8%
RP
62
Reinhart Partners
Wisconsin
$6K – – –
PNC Financial Services Group
63
PNC Financial Services Group
Pennsylvania
$5K -$3 -8 -0.1%
BIA
64
Biondo Investment Advisors
Pennsylvania
$5K – – –
HK
65
Horizon Kinetics
New York
$5K – – –
BlackRock
66
BlackRock
New York
$4K – – –
CGT
67
Capital Guardian Trust
California
$4K – – –
Truist Financial
68
Truist Financial
North Carolina
$4K – – –
LPL Financial
69
LPL Financial
California
$4K +$271 +728 +6%
RL
70
Ruffer LLP
United Kingdom
$4K +$5.2K +14,000 New
BNP Paribas Financial Markets
71
BNP Paribas Financial Markets
France
$3.12K – – –
US Bancorp
72
US Bancorp
Minnesota
$3K -$361 -970 -14%
BAM
73
Brave Asset Management
New Jersey
$3K – – –
PHIMC
74
Private Harbour Investment Management & Counsel
Ohio
$3K – – –
DA
75
Dillon & Associates
Michigan
$3K +$139 +375 +4%
1 2
3
4 5

GCVRZ Hedge Fund Activity: Q1 2014 in Review

125 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2014, worth a combined $34.8M — down 15% from $40.7M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 11 opened new positions — a net loss of 5 holders — while 27 trimmed existing stakes and 22 added.

The largest buyer was Gruss Capital Management, adding an estimated $929K. The largest seller was Abrams Capital Management, exiting entirely with an estimated $3.96M sold.

  • 125 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2014, down from 130 in Q4 2013.
  • Funds reported $34.8M of Sanofi Contingent Value Rights stock for Q1 2014, down 15% quarter-over-quarter.
  • 11 funds opened new Sanofi Contingent Value Rights positions in Q1 2014 and 16 closed out, a net change of -5 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2014 was Gruss Capital Management, an estimated $929K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2014 was Abrams Capital Management, an estimated $3.96M sold.

Based on aggregated 13F filings for Q1 2014.